WEBULL
News
BSEM
4.400
+10.00%
0.400
Weekly Report: what happened at BSEM last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at BSEM last week (1201-1205)?
Weekly Report · 12/08 10:33
Weekly Report: what happened at BSEM last week (1124-1128)?
Weekly Report · 12/01 10:28
Weekly Report: what happened at BSEM last week (1117-1121)?
Weekly Report · 11/24 10:33
Weekly Report: what happened at BSEM last week (1110-1114)?
Weekly Report · 11/17 10:34
BioStem Technologies Q3 Earnings Call Highlights Resilience
TipRanks · 11/15 00:32
BioStem Technologies Reports Q3 2025 Financial Results
TipRanks · 11/14 04:35
Press Release: BioStem Technologies Announces Filing of Restated Financial Statements
Dow Jones · 11/13 21:42
Press Release: BioStem Technologies Announces -2-
Dow Jones · 11/13 21:42
BioStem Technologies GAAP EPS of $0.03, revenue of $10.47M
Seeking Alpha · 11/13 21:17
Weekly Report: what happened at BSEM last week (1103-1107)?
Weekly Report · 11/10 10:31
Weekly Report: what happened at BSEM last week (1027-1031)?
Weekly Report · 11/03 10:31
BioStem Technologies’ Promising Clinical Trial for Venous Leg Ulcers: A Potential Game-Changer
TipRanks · 10/27 21:59
BioStem Technologies’ Promising Study on Diabetic Foot Ulcers: A Potential Game-Changer
TipRanks · 10/27 20:09
Weekly Report: what happened at BSEM last week (1020-1024)?
Weekly Report · 10/27 10:35
Weekly Report: what happened at BSEM last week (1013-1017)?
Weekly Report · 10/20 10:31
Weekly Report: what happened at BSEM last week (1006-1010)?
Weekly Report · 10/13 10:34
Weekly Report: what happened at BSEM last week (0929-1003)?
Weekly Report · 10/06 10:30
Weekly Report: what happened at BSEM last week (0922-0926)?
Weekly Report · 09/29 10:32
Weekly Report: what happened at BSEM last week (0915-0919)?
Weekly Report · 09/22 10:32
More
Webull provides a variety of real-time BSEM stock news. You can receive the latest news about Biostem Tech through multiple platforms. This information may help you make smarter investment decisions.
About BSEM
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap2 is a placental-based allograft comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.